Thelansis

 Gastric cancer ranks the fourth most prevalent malignancy among men and the seventh among women. In the context of this disease, fibroblast growth factors (FGFs) play a critical role by binding to FGFR, subsequently leading to phosphorylation at intracellular tyrosine residues. This, in turn, triggers downstream signaling activation. In roughly 30% of gastric carcinomas, there is an observable overexpression of the FGFR2 protein. This overexpression correlates positively with scirrhous cancer, a diffuse type of cancer, invasion depth, infiltration type, and a less favorable prognosis. Approximately 5-10% of gastric cancer patients exhibit amplification of FGFR2. Several factors are associated with an elevated risk of developing gastric cancer. These factors encompass dietary elements such as high-salt intake from salt-preserved foods, consumption of N-nitroso compounds from dietary sources, smoking, inadequate intake of vitamins A and C, excessive consumption of smoked or cured fo...

 Gastric cancer is the fourth most common malignant disease in men and the fifth in women. Fibroblast growth factors (FGFs) bind to FGFR, which subsequently undergoes phosphorylation at intracellular tyrosine residues, leading to the activation of downstream signalling. FGFR2 protein overexpression was observed in about 30% of gastric carcinomas and was positively correlated with scirrhous cancer, a diffuse type, invasion depth, infiltration type and a poor prognosis. The amplification of FGFR2 has been evident in approximately 5-10% of gastric cancer patients. FGFR2 amplification occurs more frequently in diffuse-type gastric cancer. However, there was no association found of FGFR2 amplification with histological subtype. Thelansis’s “Gastric Cancer Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical pr...